VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Ventripoint’s technology in routine clinical practice”.

<< Previous

Bullboard Posts

Next >>

Comment by jopatcloon Jun 15, 2024 7:03am

31 Views

Post# 36090381

RE:RE:RE:RE:RE: Ventripoint’s technology in routine clinical practice”.

jopatclo wrote: % TDGAFAU and good comment @Anima lots of positives. Upcoming potential oversubscription. Ascend update. 4.0 approval in the summer. Brazil coming into play soon.

@TDGAFAU FDA can come anytime. Padding yourself by saying End of Summer is the safe play. It is Wise to let the announcement be a surprise. Keep that in Mind in case it comes out of nowhere and everyone mind

6
about 2 hours ago

@TDGAFAU I do like the direction this company is now going and who is behind the Wheel. Not praising just yet, but so far looks favorable